174 related articles for article (PubMed ID: 11919556)
21. The PKD2 gene: structure, interactions, mutations, and inactivation.
Somlo S
Adv Nephrol Necker Hosp; 1999; 29():257-75. PubMed ID: 10561749
[No Abstract] [Full Text] [Related]
22. [Autosomal recessive polycystic kidney disease].
Ariceta G; Lens XM
Nefrologia; 2003; 23 Suppl 1():23-8. PubMed ID: 12708360
[No Abstract] [Full Text] [Related]
23. Cystin, cilia, and cysts: unraveling trafficking determinants.
Hurd TW; Margolis B
J Am Soc Nephrol; 2009 Dec; 20(12):2485-6. PubMed ID: 19875808
[No Abstract] [Full Text] [Related]
24. [Pathogenesis of cystic kidney diseases].
Walz G
Verh Dtsch Ges Pathol; 2002; 86():138-44. PubMed ID: 12647363
[TBL] [Abstract][Full Text] [Related]
25. [Gene diagnosis of autosomal dominant polycystic kidney disease type 2 using microsatellite DNA tightly linked to polycystic kidney disease gene 2].
Zhang WL; Zhang DY; Wu YM; Sun TM; Mei CL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):325-8. PubMed ID: 15300626
[TBL] [Abstract][Full Text] [Related]
26. Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease.
Harris PC; Bae KT; Rossetti S; Torres VE; Grantham JJ; Chapman AB; Guay-Woodford LM; King BF; Wetzel LH; Baumgarten DA; Kenney PJ; Consugar M; Klahr S; Bennett WM; Meyers CM; Zhang QJ; Thompson PA; Zhu F; Miller JP
J Am Soc Nephrol; 2006 Nov; 17(11):3013-9. PubMed ID: 17035604
[TBL] [Abstract][Full Text] [Related]
27. Signal transduction. Mating, channels and kidney cysts.
Emmons SW; Somlo S
Nature; 1999 Sep; 401(6751):339-40. PubMed ID: 10517627
[No Abstract] [Full Text] [Related]
28. [The nephrologists and renal polycystic disease].
Lens XM
Nefrologia; 2002; 22(5):412-3. PubMed ID: 12497741
[No Abstract] [Full Text] [Related]
29. [Gene diagnosis and clinical characteristics of autosomal recessive polycystic kidney disease].
Liu SP; Ding J
Zhonghua Er Ke Za Zhi; 2013 Apr; 51(4):311-3. PubMed ID: 23927809
[No Abstract] [Full Text] [Related]
30. Pseudoexon activation in the PKHD1 gene: a French founder intronic mutation IVS46+653A>G causing severe autosomal recessive polycystic kidney disease.
Michel-Calemard L; Dijoud F; Till M; Lambert JC; Vercherat M; Tardy V; Coubes C; Morel Y
Clin Genet; 2009 Feb; 75(2):203-6. PubMed ID: 19021639
[No Abstract] [Full Text] [Related]
31. Mutation detection for exons 2 to 10 of the polycystic kidney disease 1 (PKD1)-gene by DGGE.
Peters DJ; Ariyurek Y; van Dijk M; Breuning MH
Eur J Hum Genet; 2001 Dec; 9(12):957-60. PubMed ID: 11840199
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis, pathogenesis, and treatment prospects in cystic kidney disease.
Bergmann C; Frank V; Küpper F; Kamitz D; Hanten J; Berges P; Mager S; Moser M; Kirfel J; Büttner R; Senderek J; Zerres K
Mol Diagn Ther; 2006; 10(3):163-74. PubMed ID: 16771602
[TBL] [Abstract][Full Text] [Related]
33. Autosomal dominant polycystic kidney disease: pathophysiology and treatment.
Rapoport J
QJM; 2007 Jan; 100(1):1-9. PubMed ID: 17164322
[No Abstract] [Full Text] [Related]
34. Recent advances in understanding ion transport mechanisms in polycystic kidney disease.
Sudarikova AV; Vasileva VY; Sultanova RF; Ilatovskaya DV
Clin Sci (Lond); 2021 Nov; 135(21):2521-2540. PubMed ID: 34751394
[TBL] [Abstract][Full Text] [Related]
35. Co-inheritance of a PKD1 mutation and homozygous PKD2 variant: a potential modifier in autosomal dominant polycystic kidney disease.
Dedoussis GV; Luo Y; Starremans P; Rossetti S; Ramos AJ; Cantiello HF; Katsareli E; Ziroyannis P; Lamnissou K; Harris PC; Zhou J
Eur J Clin Invest; 2008 Mar; 38(3):180-90. PubMed ID: 18257781
[TBL] [Abstract][Full Text] [Related]
36. [Adult dominant polycystic kidney disease: molecular mechanisms and new therapeutic possibilities].
Rodríguez Pérez JC; Torres MJ
Nefrologia; 2006; 26(6):651-2. PubMed ID: 17227240
[No Abstract] [Full Text] [Related]
37. [Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease].
Joly D
Med Sci (Paris); 2011 Mar; 27(3):249-51. PubMed ID: 21447293
[No Abstract] [Full Text] [Related]
38. [Mutation detection of PKD1 gene in patients with autosomal dominant polycystic kidney diseases].
Li L; Li LY; Zhong CG; Gao BD; Lu GX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):666-9. PubMed ID: 18067079
[TBL] [Abstract][Full Text] [Related]
39. Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD).
Sweeney WE; Avner ED
Cell Tissue Res; 2006 Dec; 326(3):671-85. PubMed ID: 16767405
[TBL] [Abstract][Full Text] [Related]
40. Novel human pathological mutations. Gene symbol: PKD1. Disease: human autosomal dominant polycystic kidney disease.
Li L
Hum Genet; 2007 Nov; 122(3-4):413-4. PubMed ID: 18350644
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
